Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 192 participants.
Also called NCT05081921
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 192 participants
- Registry
-
NCT05081921 -
2019-005000-17
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Poland
- Registry status
- Completed
Technical summary
Registry record NCT05081921. Randomized; quadruple masking; primary purpose treatment. Start 2022-01-05 (actual); primary completion 2024-02-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases
- Acronym
- BioMiStem-CT
- Condition
- Osteoarthritis of Knee
- Intervention (Drug)
- MesoCellA-Ortho administration
- Intervention (Drug)
- HA administration
- Lead sponsor
- Jagiellonian University
- Collaborator
- National Center for Research and Development, Poland
- Collaborator
- KCRI
Record details
- Record id
cardio:ct-nct05081921- Content hash
bcaa422e8055d1d85419d5c5f060b21ce7e14c05a37e58a78fe2093b80180121